Terminalia and Reduced Inflammation

• Terminalia arjuna in coronary artery disease: ethnopharmacology, pre-clinical, clinical & safety evaluation.

  • 2014-09
  • Review
  • Journal of ethnopharmacology 155(2)
  • • Divya Kapoor
    • Rajesh Vijayvergiya
    • Veena Dhawan

  • PubMed: 25014508
  • DOI: 10.1016/j.jep.2014.06.056

  6 Insights on

  • Reduced Inflammation

  • Low evidence

  Evidence from various in vitro, in vivo and clinical trials reveal the pleiotropic effects of Terminalia arjuna such as anti-atherogenic, hypotensive, inotropic, anti-inflammatory, anti-thrombotic and antioxidant actions

  Effect

  Beneficial

  Effect size

  Small

  Significant

  Yes